Relationship between serum concentration of teicoplanin and efficacy and side effects in the elderly patients

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2100046811

Enrollment

Unknown

Registered

2021-05-28

Start date

2021-05-28

Completion date

Unknown

Last updated

2022-01-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infection

Interventions

case series:Nil

Eligibility

Sex/Gender

All

Age

85 Years to 110 Years

Inclusion criteria

Inclusion criteria: 1. Patients with severe infection in PLA General Hospital; 2. Apache II score >= 15 points; 3. There is a clear etiological diagnosis; 4. Age >= 85 years old; 5. Signed the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant women and lactation patients; 2. Allergic to the study drug.

Design outcomes

Primary

Measure	Time frame
Serum concentration of teicolanin;	—

Countries

China

Contacts

Public ContactLi Hongxia

Chinese PLA General Hospital

lhxsls@sina.com+86 18501328669

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 6, 2026